Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
申请人:Pfizer Inc.
公开号:EP2481735A1
公开(公告)日:2012-08-01
Compounds of the general Formula (I),
wherein X1, X2, X3, X4, X5, X6, X7, R1, R2, R4, R5, R6, R7, R8, R9, R10, C, D, Y1, n, m, p and q are defined as in the description, their preparation and their use as antimicrobial agents.
通式 (I) 的化合物、
其中,X1、X2、X3、X4、X5、X6、X7、R1、R2、R4、R5、R6、R7、R8、R9、R10、C、D、Y1、n、m、p 和 q 的定义如描述、制备和用作抗菌剂中所述。